Global Prostatic Artery Embolization Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1715

PAE is a non-surgical way of treating an enlarged and troublesome prostate by blocking off the arteries that feed the gland and making it shrink. It is performed by an interventional radiologist, rather than a surgeon, and is an alternative to a TURP (trans urethral resection of prostate) operation. PAE was first performed in 2009, and since then over 200 men have had the procedure performed predominantly in Portugal and Brazil. University Hospital Southampton has been offering a PAE service from April 2012 and is the first UK centre to perform this procedure.
In 2018, the global Prostatic Artery Embolization market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Prostatic Artery Embolization status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostatic Artery Embolization development in United States, Europe and China.

The key players covered in this study
UNC Health Care
Tampa General Hospital
Henry Ford
Spire Healthcare
...

Market segment by Type, the product can be split into
Type 1
Type 2

Market segment by Application, split into
Yonger than 60
60-85
Older than 85

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostatic Artery Embolization status, future forecast, growth opportunity, key market and key players.
To present the Prostatic Artery Embolization development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prostatic Artery Embolization are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostatic Artery Embolization Market Size Growth Rate by Type (2014-2025)
1.4.2 Type 1
1.4.3 Type 2
1.5 Market by Application
1.5.1 Global Prostatic Artery Embolization Market Share by Application (2014-2025)
1.5.2 Yonger than 60
1.5.3 60-85
1.5.4 Older than 85
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prostatic Artery Embolization Market Size
2.2 Prostatic Artery Embolization Growth Trends by Regions
2.2.1 Prostatic Artery Embolization Market Size by Regions (2014-2025)
2.2.2 Prostatic Artery Embolization Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prostatic Artery Embolization Market Size by Manufacturers
3.1.1 Global Prostatic Artery Embolization Revenue by Manufacturers (2014-2019)
3.1.2 Global Prostatic Artery Embolization Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prostatic Artery Embolization Market Concentration Ratio (CR5 and HHI)
3.2 Prostatic Artery Embolization Key Players Head office and Area Served
3.3 Key Players Prostatic Artery Embolization Product/Solution/Service
3.4 Date of Enter into Prostatic Artery Embolization Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prostatic Artery Embolization Market Size by Type (2014-2019)
4.2 Global Prostatic Artery Embolization Market Size by Application (2014-2019)

5 United States
5.1 United States Prostatic Artery Embolization Market Size (2014-2019)
5.2 Prostatic Artery Embolization Key Players in United States
5.3 United States Prostatic Artery Embolization Market Size by Type
5.4 United States Prostatic Artery Embolization Market Size by Application

6 Europe
6.1 Europe Prostatic Artery Embolization Market Size (2014-2019)
6.2 Prostatic Artery Embolization Key Players in Europe
6.3 Europe Prostatic Artery Embolization Market Size by Type
6.4 Europe Prostatic Artery Embolization Market Size by Application

7 China
7.1 China Prostatic Artery Embolization Market Size (2014-2019)
7.2 Prostatic Artery Embolization Key Players in China
7.3 China Prostatic Artery Embolization Market Size by Type
7.4 China Prostatic Artery Embolization Market Size by Application

8 Japan
8.1 Japan Prostatic Artery Embolization Market Size (2014-2019)
8.2 Prostatic Artery Embolization Key Players in Japan
8.3 Japan Prostatic Artery Embolization Market Size by Type
8.4 Japan Prostatic Artery Embolization Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prostatic Artery Embolization Market Size (2014-2019)
9.2 Prostatic Artery Embolization Key Players in Southeast Asia
9.3 Southeast Asia Prostatic Artery Embolization Market Size by Type
9.4 Southeast Asia Prostatic Artery Embolization Market Size by Application

10 India
10.1 India Prostatic Artery Embolization Market Size (2014-2019)
10.2 Prostatic Artery Embolization Key Players in India
10.3 India Prostatic Artery Embolization Market Size by Type
10.4 India Prostatic Artery Embolization Market Size by Application

11 Central & South America
11.1 Central & South America Prostatic Artery Embolization Market Size (2014-2019)
11.2 Prostatic Artery Embolization Key Players in Central & South America
11.3 Central & South America Prostatic Artery Embolization Market Size by Type
11.4 Central & South America Prostatic Artery Embolization Market Size by Application

12 International Players Profiles
12.1 UNC Health Care
12.1.1 UNC Health Care Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostatic Artery Embolization Introduction
12.1.4 UNC Health Care Revenue in Prostatic Artery Embolization Business (2014-2019)
12.1.5 UNC Health Care Recent Development
12.2 Tampa General Hospital
12.2.1 Tampa General Hospital Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostatic Artery Embolization Introduction
12.2.4 Tampa General Hospital Revenue in Prostatic Artery Embolization Business (2014-2019)
12.2.5 Tampa General Hospital Recent Development
12.3 Henry Ford
12.3.1 Henry Ford Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostatic Artery Embolization Introduction
12.3.4 Henry Ford Revenue in Prostatic Artery Embolization Business (2014-2019)
12.3.5 Henry Ford Recent Development
12.4 Spire Healthcare
12.4.1 Spire Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostatic Artery Embolization Introduction
12.4.4 Spire Healthcare Revenue in Prostatic Artery Embolization Business (2014-2019)
12.4.5 Spire Healthcare Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details